Rabelink, Ton J.

Endothelial Function and Dysfunction: Testing and Clinical Relevance

Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation

Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease Prevention

Cited by 2,710

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 792

Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy

Cantelmo, A. R., Conradi, L.-C., Brajic, A., Goveia, J., Kalucka, J., Pircher, A., Chaturvedi, P., Hol, J., Thienpont, B., Teuwen, L.-A., et al. (2016) · Cancer Cell

Angiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism

Cited by 659

Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase

Stroes, E. S. G., van Faassen, E. E., Yo, M., Martasek, P., Boer, P., Govers, R., & Rabelink, T. J. (2000) · Circulation Research

Nitric Oxide and Endothelin EffectsFolate and B Vitamins Research

Cited by 285

Postprandial recruitment of neutrophils may contribute to endothelial dysfunction

van Oostrom, A. J. H. H. M., Sijmonsma, T. P., Verseyden, C., Jansen, E. H. J. M., de Koning, E. J. P., Rabelink, T. J., & Castro Cabezas, M. (2003) · Journal of Lipid Research

Nitric Oxide and Endothelin EffectsNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 249

Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm

Gorter, P. M., Olijhoek, J. K., van der Graaf, Y., Algra, A., Rabelink, T. J., & Visseren, F. L. J. (2004) · Atherosclerosis

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk Factors

Cited by 216

Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo

Rooyakkers, T. M., Stroes, E. S. G., Kooistra, M. P., Van Faassen, E. E., Hider, R. C., Rabelink, T. J., & Marx, J. J. M. (2002) · European Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsIron Metabolism and Disorders

Cited by 157

The dialysis procedure as a trigger for atrial fibrillation: New insights in the development of atrial fibrillation in dialysis patients

Buiten, M. S., de Bie, M. K., Rotmans, J. I., Gabreëls, B. A., van Dorp, W., Wolterbeek, R., Trines, S. A., Schalij, M. J., Jukema, J. W., Rabelink, T. J., et al. (2014) · Heart

Atrial Fibrillation Management and OutcomesDialysis and Renal Disease Management

Cited by 119

Early and late adjustment to potassium loading in humans

Rabelink, T. J., Koomans, H. A., Hené, R. J., & Mees, E. J. D. (1990) · Kidney International

Potassium and Related DisordersSodium Intake and Health

Cited by 106

Development and evaluation of in vivo tissue engineered blood vessels in a porcine model

Rothuizen, T. C., Damanik, F. F. R., Lavrijsen, T., Visser, M. J. T., Hamming, J. F., Lalai, R. A., Duijs, J. M. G. J., van Zonneveld, A. J., Hoefer, I. E., van Blitterswijk, C. A., et al. (2016) · Biomaterials

Tissue Engineering and Regenerative MedicineElectrospun Nanofibers in Biomedical Applications

Cited by 84

Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages

Kraaij, M. D., van der Kooij, S. W., Reinders, M. E. J., Koekkoek, K., Rabelink, T. J., van Kooten, C., & Gelderman, K. A. (2011) · Molecular Immunology

Immune cells in cancerT-cell and B-cell Immunology

Cited by 69

Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3

van Oostrom, A. J., van Dijk, H., Verseyden, C., Sniderman, A. D., Cianflone, K., Rabelink, T. J., & Castro Cabezas, M. (2004) · The American Journal of Clinical Nutrition

Adipokines, Inflammation, and Metabolic DiseasesLipid metabolism and disorders

Cited by 53

Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice

Ellenbroek, J. H., Töns, H. A. M., Westerouen van Meeteren, M. J. A., de Graaf, N., Hanegraaf, M. A., Rabelink, T. J., Carlotti, F., & de Koning, E. J. P. (2013) · Diabetologia

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 43

Comparison of Rosiglitazone and Metformin for Treating HIV Lipodystrophy: A Randomized Trial

van Wijk, J. P. H., de Koning, E. J. P., Cabezas, M. C., op't Roodt, J., Joven, J., Rabelink, T. J., & Hoepelman, A. I. (2005) · Annals of Internal Medicine

HIV-related health complications and treatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3

Individualised treatment effects of corticosteroids in IgA nephropathy

Hölscher, D. L., Schmitz, N. E. J., Niggemeier, L., Pilva, P., Strauch, M., Tesar, V., Barratt, J., Roberts, I. S. D., Coppo, R., Barisoni, L., et al. (2026) · eBioMedicine

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 2